CNS/Neurology Market Research Reports & Industry Analysis
A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
CNS/Neurology Industry Research & Market Reports
-
2024 Global Cognitive Assessment And Training Market Industry (2030 Outlook)
... Research) The Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product ... Read More
-
Autism - Pipeline Insight, 2024
... pipeline landscape is provided, which includes the disease overview and Autism treatment guidelines. The assessment part of the report embraces in-depth Autism commercial assessment and clinical assessment of the Autism pipeline products from the pre-clinical ... Read More
-
Glioma - Pipeline Insight, 2024
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Glioma: Understanding ... Read More
-
Opioid Use Disorder (OUD) Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... market size was valued at USD 3.35 billion in 2023, and the market is now projected to grow from USD 3.62 billion in 2024 to USD 7.48 billion by 2032, exhibiting a CAGR of 9.5% ... Read More
-
Traumatic Brain Injury(TBI) - Pipeline Insight, 2024
... Injury(TBI) market. A detailed picture of the Traumatic Brain Injury(TBI) pipeline landscape is provided, which includes the disease overview and Traumatic Brain Injury(TBI) treatment guidelines. The assessment part of the report embraces in-depth Traumatic Brain ... Read More
-
Therapy Resistant Psychiatric Disorders - Pipeline Insight, 2024
... the Therapy Resistant Psychiatric Disorders market. A detailed picture of the Therapy Resistant Psychiatric Disorders pipeline landscape is provided, which includes the disease overview and Therapy Resistant Psychiatric Disorders treatment guidelines. The assessment part of ... Read More
-
Brain Tumor Therapeutics
... by 2030, growing at a CAGR of 10.5% over the period 2023-2030. MRI, one of the segments analyzed in the report, is expected to record 11.8% CAGR and reach US$2.2 Billion by the end of ... Read More
-
India Medical Cannabis Market Assessment, By Species [Indica, Sativa, Hybrid], By Derivatives [Cannabidiol, Tetrahydrocannabinol, Others], By Route of Administration [Oral, Topical, Others], By Form [Oils, Capsules, Tinctures], By Therapeutic Application [Cancer, Migraine, Epilepsy, Anxiety and Depression, Others], By End-user [Pharmaceutical Industry, Research and Development Centers, Others], By Region, Opportunities and Forecast, FY2017-FY2031F
... Depression, Others], By End-user [Pharmaceutical Industry, Research and Development Centers, Others], By Region, Opportunities and Forecast, FY2017-FY2031F India medical cannabis market is projected to witness a CAGR of 15.05% during the forecast period FY2024-FY2031, growing ... Read More
-
Precision medicine Market Assessment, By Use [Diagnostics, Therapeutics], By Application [Central Nervous System, Respiratory, Immunology, Oncology, Others], By Technology [Point-of-care Testing, Stem Cell Therapy, Pharmacogenomics, Pharmacoproteomics, Others], By End-user [Pharmaceutical Companies, Diagnostic Companies, Healthcare IT Companies, Others], By Region, Opportunities and Forecast, 2017-2031F
... Companies, Others], By Region, Opportunities and Forecast, 2017-2031F The global precision medicine market is projected to witness a CAGR of 9.73% during the forecast period 2024-2031, growing from USD 51.69 billion in 2023 to USD ... Read More
-
2024 Global Forecast for Narcotic internal analgesics and antipyretics, opium and derivatives (2025-2030 Outlook)-Manufacturing & Markets Report
... accurate market statistics and forecasts on the market for over 40 countries. The product category is within the NAICS 32511 industry. Estimates on equipment or material sales (product shipments value) are published historically for 2017 ... Read More
-
2024 Global Forecast for Narcotic internal analgesics and antipyretics, synthetic narcotics (2025-2030 Outlook)-Manufacturing & Markets Report
... accurate market statistics and forecasts on the market for over 40 countries. The product category is within the NAICS 32511 industry. Estimates on equipment or material sales (product shipments value) are published historically for 2017 ... Read More
-
2024 Global Forecast for Other pharmaceutical preparations acting on the central nervous system and the sense organs, for human use (2025-2030 Outlook)-Manufacturing & Markets Report
... accurate market statistics and forecasts on the market for over 40 countries. The product category is within the NAICS 32511 industry. Estimates on equipment or material sales (product shipments value) are published historically for 2017 ... Read More
-
2024 Global Forecast for Psychotherapeutic agents, tranquilizers, phenothiazine derivatives (2025-2030 Outlook)-Manufacturing & Markets Report
... accurate market statistics and forecasts on the market for over 40 countries. The product category is within the NAICS 32511 industry. Estimates on equipment or material sales (product shipments value) are published historically for 2017 ... Read More
-
2024 Global Forecast for Central nervous system stimulants, excluding nondrug dietaries for weight control (2025-2030 Outlook)-Manufacturing & Markets Report
... accurate market statistics and forecasts on the market for over 40 countries. The product category is within the NAICS 32511 industry. Estimates on equipment or material sales (product shipments value) are published historically for 2017 ... Read More
-
Peripheral Nerve Stimulator Market Research Report Forecast till 2030
... development because of the rising interest for Remote Peripheral Nerve Stimulators. This inclination for cutting edge, remote arrangements in neuromodulation is driving the market forward and showing an extraordinary pattern in medical care. The flood ... Read More
-
Obsessive-Compulsive Disorder - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Obsessive-Compulsive Disorder. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Borderline Personality Disorder (BPD) - Global Clinical Trials Review, 2024
... scenario. This report provides top line data relating to the clinical trials on Borderline Personality Disorder (BPD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ... Read More
-
Spinal Muscular Atrophy Market, by Type (Type I, Type II, Type III, and Type IV), by Treatment (Gene Therapy and Disease-modifying drugs), by Age Group (Infant and Adult), by Route of Administration (Oral and Injectables), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
... by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031 Spinal ... Read More
-
Global Antipsychotic Drugs Market Size Study & Forecast, by Disease (Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, and Others), By Drug (Risperidone, Quetiapine, Olanzapine, Aripiprazole, Brexpiprazole, Paliperidone Palmitate, and Others), By Therapeutic Class (First Generation, Second Generation, and Third Generation), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Analysis, 2023-2030
... Generation, and Third Generation), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Analysis, 2023-2030 Global Antipsychotic Drugs Market is valued approximately at USD 15.47 billion in 2022 and ... Read More
-
Medical Imaging Devices Market Report 2024-2034
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. High cost of devices Expensive imaging devices hinder ... Read More
-
Pharmaceutical Intermediates Global Market Opportunities And Strategies To 2033
... Drugs; Respiratory Diseases Drugs; Cardiovascular Drugs; Musculoskeletal Disorders Drugs; Metabolic Disorders Drugs4) By End-User: Biotech And Pharma Companies; Research InstitutionsCovering: BASF SE; Evonik Industries AG; Pfizer Inc.; Arkema Inc.; Koninklijke DSM N.V. Pharmaceutical Intermediates Global ... Read More
-
Cell and Gene Therapies in CNS Disorders
... therapies, and three conditionally approved cell therapies. Novartis’s Zolgensma (onasemnogene abeparvovec) for the treatment of spinal muscular atrophy (SMA) was the first CGT asset to receive traditional approval in the CNS market in 2019. Over ... Read More
-
2024 Global Forecast for Intracranial Aneurysm Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2025 ... Read More
-
2024 Global Forecast for Neuroendoscopy Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx billion in ... Read More
-
2024 Global Forecast for Narcolepsy Drug Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2025 ... Read More
Research Assistance
